Pulmonx

LUNG52

$6.09arrow_drop_down0.65%-$0.04

LUNG52

$6.09

arrow_drop_down0.65%-$0.04

Performance History

Key Stats
Open	$6.49
Prev. Close	$6.50
EPS	-1.50
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	6.25	6.56
52 Week Range	5.46	14.83

Ratios







EPS	-1.50

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Pulmonx (LUNG)

Pulmonx Corp (LUNG) is a medical technology company focused on providing minimally invasive solutions for patients with severe lung conditions. The company's flagship product, the Zephyr Endobronchial Valve System, is designed to help patients with severe emphysema breathe easier and improve their quality of life. The Zephyr valve is a small, one-way valve that is inserted into the lungs to block off damaged areas and redirect airflow to healthier parts of the lung. This innovative technology has been proven to significantly reduce shortness of breath and improve lung function in patients who have exhausted all other treatment options.

In terms of stock performance, Pulmonx Corp has shown steady growth over the years. The stock price has gradually increased since the company's initial public offering (IPO) in 2019. As of the latest trading session, the stock is trading at $42.50. The 52-week range for Pulmonx Corp stock is $25.10 to $51.80. The trading volume for LUNG stock has been relatively moderate, indicating a stable interest from investors.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Glendon E. French
Headquarters: Redwood City
Employees: 269
Exchange: NASDAQ

Keep an eye on Pulmonx

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Pulmonx (LUNG) stock price performance year to date (YTD)?

As of the latest data, Pulmonx (LUNG) has a year-to-date price change of -52.05%. Over the past month, the stock has experienced a price change of -25.64%. Over the last three months, the change has been -27.67%. Over the past six months, the figure is -18.8%.

help

What is Pulmonx's (LUNG) price per share?

The current price per share for Pulmonx (LUNG) is $6.09. The stock has seen a price change of -$0.04 recently, indicating a -0.65% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Pulmonx (LUNG)?

For Pulmonx (LUNG), the 52-week high is $14.84, which is 143.6% from the current price. The 52-week low is $5.46, the current price is 11.54% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Pulmonx (LUNG) a growth stock?

Pulmonx (LUNG) has shown an average price growth of -3.56% over the past three years. It has received a score of 11 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pulmonx as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

Is Pulmonx (LUNG) a profitable company?

Pulmonx (LUNG) has a net income of -$60.84M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 73.32% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -75.17% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $68.68M, with a revenue growth rate of 27.98%, providing insight into the company's sales performance and growth. The gross profit is $50.35M. Operating income is noted at -$61.94M. Furthermore, the EBITDA is -$56.93M.

help

What is the market capitalization of Pulmonx (LUNG)?

Pulmonx (LUNG) has a market capitalization of $240.01M. The average daily trading volume is 6.17, indicating the stock's liquidity and investor engagement.